Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 897,000 | 1,181,000 | 2,393,000 | 2,861,000 | 2,941,000 |
| Receivables | 12,185,000 | 11,763,000 | 11,778,000 | 8,603,000 | 9,021,000 |
| Inventories | 3,050,000 | 3,038,000 | 3,196,000 | 4,487,000 | 4,803,000 |
| Other current assets | 727,000 | 522,000 | 449,000 | 1,510,000 | 443,000 |
| TOTAL | $16,859,000 | $16,504,000 | $17,816,000 | $17,461,000 | $17,208,000 |
| Non-Current Assets | |||||
| PPE Net | 5,902,000 | 5,786,000 | 5,749,000 | 5,775,000 | 5,511,000 |
| Intangibles | 14,358,000 | 14,427,000 | 14,536,000 | 14,604,000 | 14,689,000 |
| Other Non-Current Assets | 8,376,000 | 8,408,000 | 8,533,000 | 8,681,000 | 11,538,000 |
| TOTAL | $28,636,000 | $28,621,000 | $28,818,000 | $29,060,000 | $31,738,000 |
| Total Assets | $45,495,000 | $45,125,000 | $46,634,000 | $46,521,000 | $48,946,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,240,000 | 750,000 | 750,000 | 750,000 | N/A |
| Accounts payable and accrued liabilities | 2,691,000 | 2,675,000 | 2,715,000 | 1,467,000 | 2,848,000 |
| Accrued Expenses | 2,165,000 | 2,051,000 | 1,771,000 | 1,785,000 | 1,895,000 |
| Other current liabilities | 2,619,000 | 1,992,000 | 2,188,000 | 1,883,000 | 2,146,000 |
| TOTAL | $15,204,000 | $13,881,000 | $13,974,000 | $12,637,000 | $13,084,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,486,000 | 13,479,000 | 13,473,000 | 13,513,000 | 14,268,000 |
| Deferred Revenues | 6,489,000 | 6,413,000 | 6,550,000 | 6,752,000 | 6,195,000 |
| Other Non-Current Liabilities | 15,744,000 | 17,223,000 | 19,227,000 | 20,906,000 | 19,342,000 |
| TOTAL | $29,289,000 | $30,765,000 | $32,771,000 | $34,493,000 | $33,687,000 |
| Total Liabilities | $44,493,000 | $44,646,000 | $46,745,000 | $47,130,000 | $46,771,000 |
| Shareholders' Equity | |||||
| Common Shares | 283,000 | 283,000 | 284,000 | 284,000 | 285,000 |
| Retained earnings | 14,737,000 | 14,528,000 | 14,123,000 | 11,573,000 | 13,173,000 |
| Other shareholders' equity | -14,077,000 | -14,395,000 | -14,589,000 | -12,540,000 | -11,360,000 |
| TOTAL | $943,000 | $416,000 | $-182,000 | $-683,000 | $2,098,000 |
| Total Liabilities And Equity | $45,436,000 | $45,062,000 | $46,563,000 | $46,447,000 | $48,869,000 |